There is still no definitive explanation of the prognostic advantage accruing from MSI, although intense lymphocytic infiltration, an increased rate of apoptosis, and infrequent allelic loss or mutation of TP53, DCC, KRAS and BRAF in MSI colorectal cancer are thought by some to determinate their clinical behavior33–35. Here, DCC is linked to colorectal cancer.